UPDATE : Wednesday, January 23, 2019
Kanzen, Corea Therapeutics to co-develop next-generation anticancer immune cell therapy by Lee Han-soo 2019-01-23 21:29
Philips Korea to increase market share for CPAP with connected care strategy by Lee Han-soo 2019-01-23 16:21
‘Trade deal with US makes it hard for Seoul to support local drugmakers’ by Kwak Sung-sun 2019-01-23 15:31
Court rejects patent registration for acute myeloid leukemia drug Vyxeos by Lee Hye-seon 2019-01-23 14:47
Legal work hour limit reduces trainee doctors’ hours of labor by Lee Min-ju 2019-01-23 11:58
Lilly returns rights for Hanmi’s BTK inhibitor candidate by Lee Han-soo 2019-01-23 10:21
Bridge Biotherapeutics licenses in new immunotherapy candidate by Lee Han-soo 2019-01-23 10:20
Court suspends FSC’s disciplinary ruling against Samsung BioLogics by Lee Han-soo 2019-01-22 22:30
Chong Kun Dang to co-promote CJ Healthcare’s gastroesophageal reflux treatment by Lee Han-soo 2019-01-22 16:03
Seoul’s disease control questioned amid spreading fears over measles by Choi Gwang-seok 2019-01-22 15:16
‘We Want Healthcare’ introduces Lunit AI to its screening system by Lee Han-soo 2019-01-22 14:56
‘Appendicitis patients' prognosis remains similar if surgery is done within 24 hours’ by Lee Han-soo 2019-01-22 14:55
Most training hospitals let unlicensed assistants perform surgeries by Lee Min-ju 2019-01-22 14:53
Drug distributors to report Novo Nordisk to antitrust watchdog over ‘unfair trade’ by Park Gi-taek 2019-01-22 14:18
BMS, Ono Pharma wins more indication for Opdivo in EU by Lee Han-soo 2019-01-21 18:01
New HIV combo pill Biktarvy approved in Korea by Lee Hye-seon 2019-01-21 15:36
JW wins sales go-ahead for hemophilia A treatment by Lee Han-soo 2019-01-21 15:35
Novo Nordisk increases market share for mixed insulin in Korea by Lee Han-soo 2019-01-21 14:44
‘Customized therapy for schizophrenia may be possible’ by Choi Gwang-seok 2019-01-21 14:43
Sillajen releases interim results for combination cancer treatment in US by Lee Han-soo 2019-01-21 14:20
Back to Top